Postrock Partners’s Exact Sciences EXAS Stock Holding History

Postrock Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,309	Closed	-$692K	–	82
2024 Q4	$692K	Buy	+12,309	New	+$766K	0.34%	48

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Postrock Partners's EXAS Position: Q1 2025 in Review

Postrock Partners sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 12,309 shares — an estimated $692K sold.

Postrock Partners first reported a position in EXAS in Q4 2024 and held it in 1 quarter. The position peaked at $692K in Q4 2024. 556 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

Postrock Partners reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
Postrock Partners sold 12,309 Exact Sciences shares in Q1 2025, an estimated $692K.
Postrock Partners first reported a position in Exact Sciences in Q4 2024 and held it in 1 quarter.
Postrock Partners's Exact Sciences position peaked at $692K in Q4 2024.
556 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Postrock Partners's 13F filing for Q1 2025, filed 2 May 2025.